DrugPatentWatch Database Preview
Roche Palo Company Profile
What is the competitive landscape for ROCHE PALO, and what generic and branded alternatives to ROCHE PALO drugs are available?
ROCHE PALO has thirteen approved drugs.
Summary for Roche Palo
| US Patents: | 0 |
| Tradenames: | 7 |
| Ingredients: | 8 |
| NDAs: | 13 |
| Patent Litigation for Roche Palo: | See patent lawsuits for Roche Palo |
Drugs and US Patents for Roche Palo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche Palo | CELLCEPT | mycophenolate mofetil | CAPSULE;ORAL | 050722-001 | May 3, 1995 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Roche Palo | CYTOVENE | ganciclovir | CAPSULE;ORAL | 020460-001 | Dec 22, 1994 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Roche Palo | TORADOL | ketorolac tromethamine | INJECTABLE;INJECTION | 019698-001 | Nov 30, 1989 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Roche Palo
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Roche Palo | CELLCEPT | mycophenolate mofetil | SUSPENSION;ORAL | 050759-001 | Oct 1, 1998 | 5,688,529 | Start Trial |
| Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | 5,543,408 | Start Trial |
| Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | 4,753,935 | Start Trial |
| Roche Palo | AEROBID | flunisolide | AEROSOL, METERED;INHALATION | 018340-001 | Aug 17, 1984 | 4,933,168 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ROCHE PALO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | For Oral Suspension | 200 mg/mL | ➤ Subscribe | 2011-03-25 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
